Market Tracker

08/20 10:36am ET

PDL BioPharma Inc (NASDAQ:PDLI)

9.53
Real-Time Quote
 -0.02 / -0.21%
Today’s Change
7.38
Today|||52-Week Range
10.21
+12.91%
Year-to-Date

Today’s Trading

Previous close9.55
Today’s open9.55
Day’s range9.46 - 9.60
Volume346,737
Average volume (3 months)2,167,469
Market cap$1.5B
Dividend yield6.32%
Data as of 10:21am ET, 08/20/2014

Growth & Valuation

Earnings growth (last year)+14.48%
Earnings growth (this year)+12.25%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+18.26%
P/E ratio5.4
Price/Sales2.66
Price/Book11.78

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc-0.37-0.85%
MDCOMedicines Co-0.34-1.31%
IPXLImpax Laboratories I...-0.22-0.90%
ACORAcorda Therapeutics ...-0.22-0.69%
Data as of 10:21am ET, 08/20/2014

Financials

Next reporting dateNovember 12, 2014
EPS forecast (this quarter)$0.47
Annual revenue (last year)$442.9M
Annual profit (last year)$264.5M
Net profit margin59.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts